These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6492943)

  • 21. The antihypertensive action of indapamide: results of a French multicentre study of 2,184 ambulant patients.
    Mimran A; Zambrowski JJ; Coppolani T
    Postgrad Med J; 1981; 57 Suppl 2():60-3. PubMed ID: 6119686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
    Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
    Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the combination of atenolol and indapamide in the therapy of arterial hypertension (with data concerning toxicity and tolerance in the experimental animal)].
    Anania V; Bartoli E; Desole MS; Faedda R; Miele E; Olmeo NA; Satta A; Soggia G; Vacca R
    Clin Ter; 1981 Jul; 98(1):11-23. PubMed ID: 7249570
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of indapamide in resistant hypertensive therapy.
    Dean S
    Postgrad Med J; 1981; 57 Suppl 2():26-8. PubMed ID: 6119685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indapamide in a single daily dose in the treatment of hypertension. A multicentre trial in private practice.
    Marais CA
    S Afr Med J; 1981 Jun; 59(25):900-2. PubMed ID: 7015538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of indapamide given in conjunction with captopril in severe hypertension.
    Kocijancic M; Dimkovic S
    Curr Med Res Opin; 1986; 10(5):313-8. PubMed ID: 3545687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD; Huff M; Barnett PA
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary controlled evaluation of the antihypertensive effect of indapamide.
    Turner P; Volans GN; Rogers HJ
    Curr Med Res Opin; 1977; 4(8):596-601. PubMed ID: 326495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nadolol in combination with indapamide and xipamide in resistant hypertensives.
    Dean S; Kendall MJ; Potter S; Thompson MH; Jackson DA
    Eur J Clin Pharmacol; 1985; 28(1):29-33. PubMed ID: 3987783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.